Evonik took over operation of the Tippecanoe Laboratories in Lafayette, Indiana, at the beginning of 2010. It is the company's second-largest site in the US.
In 1953, the US pharmaceutical giant, Eli Lilly and Company, built a plant to produce pharmaceuticals. Tippecanoe Laboratories was named after the county in which it resides. Over the years, the site grew to its current size. The site produces active ingredients and intermediates in two areas:
Bulk pharmaceutical manufacturing for active pharmaceutical ingredients
Animal Health products for veterinary drugs
The acquisition of Tippecanoe represents an important milestone in the strategy of the Health Care Business Line. Evonik has production plants in China and Europe, and now also in the US, and can offer customized production for customers worldwide.
At a glance
Total area 9.5 square kilometers (approximately 2350 acres)
1 square kilometer (approximately 250 acres) of factories
4.5 square kilometers (approximately 1100 acres) of farmland
4 square kilometers (approximately 1000 acres) of wildlife habitat
Active ingredients and intermediates for cancer drugs and veterinary drugs.
Facility is known for advanced particle engineering expertise to ensure successful HPAPI formulations
Large fermentation capacity
170 m3 of versatile HPAPI capacity able to handle OEL levels to 0.1 µg/m3 and experience from kilos to tonnes to serve clients custom HPAPI development and manufacturing projects.
High potency API client projects benefit from: